Departments

Medical Departments

Nuclear Medicine Department

Research : Projects

See also the general heading "Research&Development"

 

Diagnostic Projects:

• FDG-PET/CT and Tc99m-Sestamibi for response assesssment of Multiple Myeloma
• FDG-PET/CT for assesing residual disease after chemoradiation therapy in head and neck cancer
• FDG-PET-CT in thyroid cancer.
• FDG-PET-CT in therapy resistant prostate cancer.
• Sentinel node biopsy in prostate cancer.
• Sentinel node biopsy in head and neck cancer.

• Etude de la captation de radio-iodes dans les cancers mammaires métastatiques

• Etude de l’expression du NIS (protéine membranaire responsable de la captation cellulaire de l’iode) dans les cancers thyroïdiens, les cancers mammaires et leurs métastases
• PET-CT au moyen de l’iode-124 dans les cancers thyroïdiens

Radionuclide Therapy studies:

• Treatment of unresectable livermetastasis with Yttrium-90 labeled microspheres
• Treatment of hepatocellular carcinoma with Yttrium-90 labeled microspheres
• Dosimetry of Yttrium-90 labeled microspheres (PET-SPECT-CT image fusion)
• Dosimetry based approach for thyroid cancer therapy with Iodine-131.
• Traitement des cancers thyroïdiens après essai de rédifférenciation par l’acide 13-cis-rétinoique

Contract Research with Pharmaceutical Industry:

• Serial FDG-PET/CT for assessment of treatment efficacy of new drugs
• Serial FDG-PET/CT in Phase I and Phase II clinical studies.

Person in charge : Pr Patrick Flamen

Last reading of this page : January 2008